List of Excipients in API etonogestrel
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing etonogestrel
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Organon USA Inc | NEXPLANON | etonogestrel | 0052-4330 | BARIUM SULFATE | 2027-09-28 |
| Organon USA Inc | NEXPLANON | etonogestrel | 0052-4330 | ETHYLENE-VINYL ACETATE COPOLYMER | 2027-09-28 |
| Organon USA Inc | NEXPLANON | etonogestrel | 0052-4330 | MAGNESIUM STEARATE | 2027-09-28 |
| Organon LLC | NEXPLANON | etonogestrel | 78206-145 | BARIUM SULFATE | 2027-09-28 |
| Organon LLC | NEXPLANON | etonogestrel | 78206-145 | ETHYLENE-VINYL ACETATE COPOLYMER | 2027-09-28 |
| Organon LLC | NEXPLANON | etonogestrel | 78206-145 | MAGNESIUM STEARATE | 2027-09-28 |
| Organon USA Inc | NUVARING | etonogestrel and ethinyl estradiol | 0052-0273 | ETHYLENE-VINYL ACETATE COPOLYMER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing etonogestrel
Detailed excipient profiles for etonogestrel
Excipient focus: BARIUM SULFATE
etonogestrel drug variants containing BARIUM SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Organon USA Inc | etonogestrel | 0052-4330 |
| Organon LLC | etonogestrel | 78206-145 |
| >Company | >Ingredient | >NDC |
etonogestrel drug variants not containing BARIUM SULFATE
Excipient focus: ETHYLENE-VINYL ACETATE COPOLYMER
etonogestrel drug variants containing ETHYLENE-VINYL ACETATE COPOLYMER
etonogestrel drug variants not containing ETHYLENE-VINYL ACETATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
etonogestrel drug variants containing MAGNESIUM STEARATE
etonogestrel drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
